Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
- If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
- If you log in with a username and password, you will be prompted to set a new password before accessing your account.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Hua Medicine (Shanghai) Co. Ltd.
Headquarters: Shanghai, China
Website: https://www.huamedicine.com/En...
Year Founded: 2011
Status: Public
Industry Sector: HealthTechnology
CEO: Li Chen, PhD
Number Of Employees: 168
Enterprise Value: $68,244,767
PE Ratio: -8.18
Exchange/Ticker 1: HKEX:2552
Exchange/Ticker 2: N/A
Latest Market Cap: $285,016,885
BioCentury | Feb 22, 2024
Politics, Policy & Law
Bob Nelsen on AI, China and the IRA
Arch Venture Partners’ co-founder discusses the biotech industry’s challenges and opportunities
BioCentury | Oct 11, 2022
Product Development
Oct. 10 Quick Takes: WuXi Biologics clears one unit from U.S. watch list
Plus liver disease RNA company Ochre raises $30M, and updates from Supernus, RadioMedix, Hua, JW and scPharmaceuticals
BioCentury | Mar 17, 2022
Finance
March 17 Quick Takes: MPP brings royalty-free Paxlovid to 95 countries
Plus China stocks rise again, Deepcell raises and updates from Qbic, AbbVie and more
BioCentury | Sep 27, 2021
Product Development
Hua’s diabetes therapy may be first to show clinical remission
Early stage Type II diabetes patients maintain HbA1c target after use of GCK activator dorzagliatin
BioCentury | Apr 27, 2021
Regulation
April 26 Quick Takes: U.S. to release 60M doses of AZ vaccine to other countries; plus IP pact, ADC, GSK, uniQure, Hua, Reata, Axsome and more
The U.S. will release 60 million doses of the COVID-19 vaccine from AstraZeneca plc (LSE:AZN; NASDAQ:AZN) and the University of Oxford to other countries as they become available, according to Andy
BioCentury | Nov 14, 2020
Deals
Innovation in a hurry: China biotechs see a fast track to global stage – survey
BioCentury, BayHelix survey finds China biotechs expect to fund their own growth but will need global deals to accelerate at a pace that meets their ambition
BioCentury | Aug 17, 2020
Deals
China’s Hua looks to Bayer to commercialize lead diabetes therapy on its own turf
China’s top diabetes sales force to sell first-in-class GCK activator dorzagliatin
BioCentury | Jul 2, 2020
Product Development
July 1 Quick Takes: Amgen gains on court win; plus Hua, J&J, argenx, Seattle Genetics-Genmab, Interprotein
BioCentury | Jun 19, 2020
Product Development
Hua shows sustained benefit in diabetics with glucokinase activator
BioCentury | Feb 15, 2020
Management Tracks
Immunomedics names Itri CMO; plus Hua, GenMark, AAM, Vividion, Sophia Genetics, Enterprise, Encoded, Palleon and more
Items per page:
1 - 10 of 43